Bright Minds Biosciences DRUG
NASDAQ DRUG
$50.44 -4.76 (-8.62%)
At close: Oct 21, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) EV to EBIT (2025)

Updated

Bright Minds Biosciences' (DRUG) EV to EBIT stood at 17.55 in fiscal Q3 2025 (quarter ended Jun 30, 2025), down 93.5% from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) EV to EBIT (2025) Analysis & Trends

On a TTM basis, Bright Minds Biosciences' EV to EBIT came in at -0.74 as of Jun 30, 2025.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Bright Minds Biosciences 343.90 Mn -219.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 17.45
Mar 31, 2025 269.26
API Access

Bright Minds Biosciences EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=DRUG&period=max&api_key=YOUR_API_KEY